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AbstRACt
Peptic ulcer disease is a rare cause of rapidly progressing anaemia in pregnancy, especially during the second trimester 
of pregnancy. Making a definitive diagnosis in this group of patients is usually very tasking, especially when the common 
causes of anemia in pregnancy such as Malaria, Sickle Cell Disease, Upper respiratory tract infection, nutritional anemia, 
e.g., iron and folate deficiency anemia and ruptured ectopic gestation are excluded. We present a rare cause of rapidly 
progressing mid‑trimester severe anemia in pregnancy secondary to peptic ulcer disease in pregnancy, along with the 
diagnostic challenges, multidisciplinary management, literature review, and the follow‑up care.
Key words: Eosophagogastroduodenoscopy; Havana Specialist Hospital Limited; peptic ulcer disease in pregnancy; rapidly 
progressing severe anemia.
Introduction
Peptic ulcer disease is quite uncommon in pregnancy and 
a rare cause of rapidly progressing anemia in pregnancy. 
Making a definitive diagnosis and instituting timely and 
appropriate management may be quite challenging because 
of the remarkable anatomical and physiological changes 
that the gastrointestinal tract (GIT) has undergone during 
pregnancy and the safety of the investigating tools such 
as radiological investigations and restriction in drug use 
during pregnancy.
However, promptness in arriving at a definitive diagnosis and 
commencing appropriate management will prevent maternal 
and perinatal morbidities and mortalities in these patients.
This paper reports a rare cause of rapidly progressing severe 
anemia in mid-trimester of pregnancy, secondary to peptic 
ulcer disease in pregnancy, in a primigravid woman in a 
private tertiary health care facility in Lagos, Nigeria.
Case Report
An unbooked 29-year-old G1Po
+0 woman at 18 weeks 
gestation was admitted through our outpatient department 
with 2-day history of generalized body weakness, vomiting, 
and poor appetite. There was no history of bleeding per 
vaginam. She was not a known diabetic and there was no 
history of peptic ulcer disease. She was a known asthmatic 
and on inhaler use whenever she had an attack. Her last 
asthmatic attack was a year before presentation at our facility. 
Peptic ulcer disease in pregnancy: A rare cause of rapidly 
progressing anemia in mid‑trimester of pregnancy – A case 
report and literature review
Iwuala IC, Afolabi-Oluyede MO, Olanrewaju DR, Awolola OO1
Department of Obstetrics and Gynaecology, Havana Specialist Hospital, Surulere, Lagos, Nigeria, 1Department of Obstetrics and 
Gynaecology, State Specialist Hospital, Asubiaro, Osogbo, Osun State, Nigeria
Case Report






How to cite this article: Iwuala IC, Afolabi‑Oluyede MO, Olanrewaju DR, 
Awolola OO. Peptic ulcer disease in pregnancy: A rare cause of rapidly 
progressing anemia in mid‑trimester of pregnancy – A case report and 
literature review. Trop J Obstet Gynaecol 2018;35:84‑6.
This is an open access journal, and articles are distributed under the terms of the Creative 
Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, 
tweak, and build upon the work non-commercially, as long as appropriate credit is given and 
the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com
Iwuala, et al.: Peptic ulcer disease in pregnancy
85Tropical Journal of Obstetrics and Gynaecology / Volume 35 / Issue 1 / January‑April 2018
There was no history of use of nonsteroidal anti-inflammatory 
drugs since her last menstrual period.
At admission, her vital signs were within normal limits. The 
provisional diagnosis was malaria in pregnancy. Her packed 
cell volume was 30%, hemoglobin concentration was 10.3 g/dl, 
complete blood count, total and differentials, and platelet 
counts were normal. Blood film showed two pluses of malaria 
parasites. The mid stream urine for microscopy, culture, and 
sensitivity showed slightly turbid urine and heavy growth of 
Proteus species sensitive to cefuroxime. Pelvic ultrasound scan 
showed viable intrauterine pregnancy at 18 weeks gestation 
with adequate liquor.
She was treated with arthemisinine–lumefantrine combination 
therapy, hematinics, intramuscular maxolone 10 mg thrice 
daily, Tab. Zinnat 500 mg 12 hourly, and intravenous infusion 
of 5% dextrose saline to alternate with 5% dextrose in water 
500 ml 4 hourly.
After about 30 hours on admission, attention was drawn to 
the patient. She was restless, sweating, and had developed 
hematemesis. Her pulse rate was 122 beats per minute, 
blood pressure was 115/62 mmHg, random blood sugar 
was 105 mg/dl, packed cell volume was 15%. Hemoglobin 
concentration was 4.5 g/dl.
Abdominopelvic ultrasound scan was normal.  A provisional 
assessment of severe anemia in the second trimester of 
pregnancy secondary to Gastrointestinal bleeding was 
made. We invited the Gastroenterologists and the Surgeons 
to review. An assessment of upper gastrointestinal bleeding 
in pregnancy possibly secondary to Mallory–Weiss syndrome 
was made. She was investigated and managed accordingly. 
Endoscopy of the upper gastrointestinal tract showed normal 
esophageal and cardial parts, along with several erosions and 
areas of severe inflammation in the fundus and the upper 
body of the stomach. The duodenal parts were normal. 
The repeated packed cell volume was 12% and hemoglobin 
concentration was 3.7 g/dl. She was given intravenous 
ranitidine 300 mg stat and 50 mg 6 hourly, intravenous 
omeprazole 80 mg 8 hourly, metochlopromide 10 mg 8 
hourly and oxygen by face mask. She was transfused with 
6 pints of blood within 48 hours of making the definitive 
diagnosis. When she was clinically stable, Cap Amoxycillin 
1 g 12 hourly was added to the prescribed medications by 
the gastroenterologists. Her post-transfusion packed cell 
volume was 26% and hemoglobin concentration was 8.7 g/dl.
She was discharged home to see in the antenatal clinic and 
to continue with the routine antenatal hematinics and oral 
medications for peptic ulcer disease.
She complied with the therapy and had an uneventful antenatal 
clinic visits. Her packed cell volume ranged between 28 and 
34%. She had an emergency cesarean section at 41 weeks 
for failed induction of labor for prolonged pregnancy. The 
puerperal period was uneventful. She was educated on the 
need to comply with peptic ulcer medications. She was 
discharged to the medical outpatient department for further 
management 6 weeks postpartum period.
Discussion
Peptic ulcer disease is quite uncommon in pregnancy and 
a rare cause of rapidly progressing anemia in pregnancy, 
especially in the first and second trimester. Many researchers 
reported a decrease in the incidence of peptic ulcer 
disease in pregnancy.[1-6] Various reasons or theories have 
been proposed for this reduction in the incidence, which 
includes the increase in the gestational hormones, especially 
progesterone, that cause an increase in gastric mucus 
synthesis, reduced gastrointestinal motility, and lower gastric 
acid production in pregnancy.
Similarly, during pregnancy there is an increase in plasma 
histamine, caused by placental histaminases synthesis, which 
increases the metabolism of maternal histamine, thereby 
reducing gastric acid secretion.[6,7] Amdeslasie reported an 
incidence of 1–6 in every 23,000 pregnancies.[7] Guberman 
et al. quoted an incidence of 1 in 4000 deliveries.[4] Other 
factors for reduced incidences in pregnancy include avoidance 
of alcohol, cigarette smoking, restriction in drug use during 
pregnancy, especially NSAIDS.[7,8] Interestingly, some authors 
has reported that the reduction is due to underevaluation 
of these patients because of the restriction in the use of 
investigation tools during pregnancy such as radiological 
investigations and endoscopy.[2,8,9,10,11] Frequent treatment 
of reflux esophagitis during pregnancy with antacids is also 
a major factor for underdiagnosis.[6,9,10,11] All these must 
have contributed to our inability to make a timely definitive 
diagnosis.
The similarities in the clinical presentations of patients with 
peptic ulcer disease in pregnancy and those of pregnancy 
symptoms or reflux esophagitis also pose a big challenge 
in making a definitive diagnosis.[7,10,11] However, nausea and 
vomiting are rarely seen after 20 weeks of pregnancy but 
peptic ulcer disease often becomes worse or more severe 
during the third trimester. Our patient presented with 
nausea and vomiting at 18th week of gestation and there 
was no previous history of peptic ulcer disease or the use 
of NSAIDs. The only pointer to peptic ulcer disease in this 
pregnancy which was hematemesis was seen about 30 hours 
on admission.[12,13]
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Multidisciplinary approach to the management of these 
patients will improve outcome and reduce morbidities 
and mortalities. Thus, our patient was comanaged with 
a gastroenterologist and a surgeon who carried out the 
eesophagogastroduodenoscopy (EDG).
The goals of managing these patients are to relieve the 
symptoms, heal the ulcers, prevent complications, and 
recurrences and to minimize the occurrence of teratogenicity in 
the foetus. All these we did as a team to achieve optimal output.
In general, the first line of treatment involves lifestyle 
modifications such as avoidance of provoking foods, alcohol, 
smoking, drugs, for example, NSAIDS. Medical therapy 
includes sucralfate, an aluminum salt of sucrose, to provide a 
protective coating at the ulcer base, H2-receptor antagonists 
such as cimetidine and ranitidine, proton-pump inhibitor such 
as omeprazole and antimicrobial therapy, when Helicobacter 
pylori infection is confirmed.[2,4,5,9,14] All these groups of 
drugs have been reported to be save during pregnancy.[15,16] 
However, the prostaglandin analogue such as Misoprostol 
should be avoided, because of the risk of uterine contraction 
and abortion. Similarly, tetracyclines are teratogenic and must 
be avoided in pregnancy.
Combinations of these drugs were used for our patient 
because of the severity of her condition. We however avoided 
the teratogenic ones.
Conclusion
Peptic ulcer disease, though said to be a rare occurrence 
during pregnancy, are seen more often than documented in 
obstetric practice because they are under-diagnosed. When 
it occurs in pregnancy, the challenges in making a definitive 
diagnosis may cause a delay in instituting a timely and 
appropriate treatment, resulting in an increase in maternal 
and perinatal morbidities and mortalities. Our case should 
actually be termed a “Near miss.” Therefore, health care givers 
should always consider peptic ulcer disease as a differential 
diagnosis in pregnant women with gastrointestinal disorders.
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